We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.40 | -1.89% | 176.60 | 176.20 | 176.60 | 182.20 | 176.20 | 181.40 | 2,044,907 | 16:35:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Health & Allied Services,nec | 1.51B | 25.4M | 0.0631 | 27.92 | 724.95M |
From Mar 2020 to Mar 2025
TIDMSPI TIDMMDC
RNS Number : 6629V
Spire Healthcare Group PLC
06 November 2017
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Full name of discloser: SPIRE HEALTHCARE GROUP PLC ---------------------------------------------------------- ---------------------------------------------------------- (b) Owner or controller of interests and short positions N/A disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. ---------------------------------------------------------- ---------------------------------------------------------- (c) Name of offeror/offeree in relation to whose relevant SPIRE HEALTHCARE GROUP PLC (OFFEREE) securities this form relates: Use a separate form for each offeror/offeree ---------------------------------------------------------- ---------------------------------------------------------- (d) Is the discloser the offeror or the offeree? OFFEREE ---------------------------------------------------------- ---------------------------------------------------------- (e) Date position held: 3 NOVEMBER 2017 The latest practicable date prior to the disclosure ---------------------------------------------------------- ---------------------------------------------------------- (f) In addition to the company in 1(c) above, is the YES, IN RESPECT OF MEDICLINIC INTERNATIONAL PLC (AS discloser making disclosures in respect OFFEROR) of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" ---------------------------------------------------------- ---------------------------------------------------------- 2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates
Hot Features
Premium
Class of relevant security: Ordinary Shares of 1 pence
------------------------------------------------------------------------------- -------------------------------------
Interests Short positions
------------------------------------------------------------------------------- ----------------- ------------------
Number % Number %
------------------------------------------------------------------------------- ------------ --- --------------
(1) Relevant securities owned and/or controlled: Nil - Nil -
------------------------------------------------------------------------------- ------------ --- --------------
(2) Cash-settled derivatives: Nil - Nil -
------------------------------------------------------------------------------- ------------ --- --------------
(3) Stock-settled derivatives (including options) and agreements to Nil - Nil -
purchase/sell:
------------------------------------------------------------------------------- ------------ --- --------------
Nil - Nil -
TOTAL:
------------------------------------------------------------------------------- ------------ --- --------------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: NONE
---------------------------------------------------------------------------- -----
Details, including nature of the rights concerned and relevant percentages: NONE
---------------------------------------------------------------------------- -----
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including directors' and
other employee options) of any person acting in concert with the party to the offer making
the disclosure:
---------------------------------------------------------------------------------------------------
3(a) Interests of directors of Spire Healthcare Group plc in Spire Healthcare Group plc ordinary
shares
Director Number of ordinary Percentage of
shares total issued
share capital
(excluding treasury
shares) (%)
---------------- ------------------- ---------------------
Garry Watts 503,777 0.13%
---------------- ------------------- ---------------------
Tony Bourne 11,904 0.00%
---------------- ------------------- ---------------------
Simon Gordon 537,332 0.13%
---------------- ------------------- ---------------------
Janet Husband 10,231 0.00%
---------------- ------------------- ---------------------
Simon Rowlands 214,516 0.05%
---------------- ------------------- ---------------------
Justin Ash 89,000 0.02%
---------------- ------------------- ---------------------
3(b) Options held by directors of Spire Healthcare Group plc in its ordinary shares
Simon Gordon
Name Grant Shares in Exercise Exercise
Date respect of price Date/Exercise
which options Period
granted
------------ --------- --------------- --------- ---------------
LTIP Scheme 1 April 193,905 Nil cost No later
2015 2015 option than 1 April
2025
------------ --------- --------------- --------- ---------------
LTIP Scheme 30 March 197,628 Nil cost No later
2016 2016 option than 30 March
2026
------------ --------- --------------- --------- ---------------
LTIP Scheme 30 March 223,146 Nil cost No later
2017 2017 option than 30 March
2027
------------ --------- --------------- --------- ---------------
Deferred 1 June 10,922 Nil cost 1 June 2018
Bonus Plan 2015 option to 1 June
2025
------------ --------- --------------- --------- ---------------
---------------------------------------------------------------------------------------------------
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" ------------------------------------------------------------------------------------------------ NONE ------------------------------------------------------------------------------------------------ (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" ---------------------------------------------------------------------------------------------- NONE ---------------------------------------------------------------------------------------------- (c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO ------------------------------------- --- Supplemental Form 8 (SBL) NO ------------------------------------- --- Date of disclosure: 6 November 2017 --------------------- ---------------- Contact name: Daniel Toner --------------------- ---------------- Telephone number: 02074 279080 --------------------- ----------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FEEUNVARBOAARAA
(END) Dow Jones Newswires
November 06, 2017 06:59 ET (11:59 GMT)
1 Year Spire Healthcare Chart |
1 Month Spire Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
